Afficher la notice abrégée

Arm-swing kinematics in Parkinson's disease: A systematic review and meta-analysis.

dc.contributor.authorNavarro-López, Víctor
dc.contributor.authorFernández-Vázquez, Diego
dc.contributor.authorMolina-Rueda, Francisco
dc.contributor.authorCuesta-Gómez, Alicia
dc.contributor.authorCarratalá Tejada, Maria
dc.date.accessioned2024-01-15T11:52:44Z
dc.date.available2024-01-15T11:52:44Z
dc.date.issued2022-10
dc.identifier.citationNavarro-López V, Fernández-Vázquez D, Molina-Rueda F, Cuesta-Gómez A, García-Prados P, Del-Valle-Gratacós M, Carratalá-Tejada M. Arm-swing kinematics in Parkinson's disease: A systematic review and meta-analysis. Gait Posture. 2022 Oct;98:85-95es
dc.identifier.urihttps://hdl.handle.net/10115/28440
dc.description.abstractBackground: Parkinson’s disease (PD) causes postural instability and gait abnormalities that may be associated with an arm swing reduction. Objective: To conduct systematic review and meta-analysis to determine the kinematic patterns of arm-swing during gait in people with PD Methods: A computer literature search of the PubMed, EMBASE, WOS, PEDro, SCOPUS and SciELO databases was conducted. Terms related to PD and arm-swing were combined to find studies that performed a free walking evaluation of the arm-swing of PD patients on or off medication compared to healthy controls. After a standardized evaluation by three examiners, fifteen articles met inclusion criteria. Random effects meta-analysis models were utilized to quantify (1) the arm-swing range of motion (RoM); (2) the arm-swing amplitude; (3) the arm-swing velocity; and (4) the arm-swing asymmetry. Results: On average, arm-swing RoM (7.07◦), amplitude (0.8 cm), and velocity (0.31 m/s) were significantly decreased in PD compared to healthy controls. Healthy subjects had significantly more symmetrical arm-swing (8.16%) than people with PD. Effect sizes were moderate-large. Conclusions: People with PD have significant differences in RoM, amplitude, velocity, and asymmetry of armswing during gait compared to the healthy control group. Medication phase does not significantly influence arm-swing characteristics. Further studies will be needed to determine whether different disease characteristics influence the biomechanics of arm-swing during gait.es
dc.language.isoenges
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectArm swinges
dc.subjectBiomechanicses
dc.subjectGait analysises
dc.subjectParkinson diseasees
dc.titleArm-swing kinematics in Parkinson's disease: A systematic review and meta-analysis.es
dc.typeinfo:eu-repo/semantics/articlees
dc.identifier.doi10.1016/j.gaitpost.2022.08.017es
dc.rights.accessRightsinfo:eu-repo/semantics/embargoedAccesses


Fichier(s) constituant ce document

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Attribution-NonCommercial-NoDerivatives 4.0 InternacionalExcepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NonCommercial-NoDerivatives 4.0 Internacional